Format
Items per page
Sort by

Send to:

Choose Destination

Results: 12

Related Articles by Review for PubMed (Select 10637076)

1.

Carcinosarcoma of the ovary in a patient with a germline BRCA2 mutation: evidence for monoclonal origin.

Sonoda Y, Saigo PE, Federici MG, Boyd J.

Gynecol Oncol. 2000 Feb;76(2):226-9.

PMID:
10637076
2.

Histology of prophylactically removed ovaries from BRCA1 and BRCA2 mutation carriers compared with noncarriers in hereditary breast ovarian cancer syndrome kindreds.

Casey MJ, Bewtra C, Hoehne LL, Tatpati AD, Lynch HT, Watson P.

Gynecol Oncol. 2000 Sep;78(3 Pt 1):278-87. Review.

PMID:
10985881
3.

BRCA1 and BRCA2 and the genetics of breast and ovarian cancer.

Welcsh PL, King MC.

Hum Mol Genet. 2001 Apr;10(7):705-13. Review.

4.

Is TP53 dysfunction required for BRCA1-associated carcinogenesis?

Schuyer M, Berns EM.

Mol Cell Endocrinol. 1999 Sep 10;155(1-2):143-52. Review.

PMID:
10580847
5.

Laboratory identification of hereditary risk of breast and ovarian cancer.

Frank TS.

Curr Opin Biotechnol. 1999 Jun;10(3):289-94. Review. No abstract available.

PMID:
10361081
6.

Breast conservation in BRCA1 or BRCA2 mutation carriers with early stage breast cancer.

Phillips KA, McKay MJ.

Australas Radiol. 2001 May;45(2):200-4. Review.

PMID:
11380364
7.

Prevention and therapy for BRCA1/2 mutation carriers and women at high risk for breast and ovarian cancer.

Kuschel B, Lux MP, Goecke TO, Beckmann MW.

Eur J Cancer Prev. 2000 Jun;9(3):139-50. Review.

PMID:
10954253
8.

Role of BRCA gene dysfunction in breast and ovarian cancer predisposition.

Scully R.

Breast Cancer Res. 2000;2(5):324-30. Epub 2000 Jul 13. Review.

9.

A case of loss of heterozygosity in the BRCA2 gene of a borderline ovarian tumor: case report and review of literature.

Verbruggen MB, Zweemer RP, Piek JM, van Unnik GA, van Diest PJ, Gille JJ, Menko FH, Dorsman JC, Verheijen RH.

Int J Gynecol Cancer. 2007 Sep-Oct;17(5):1143-7. Epub 2007 Mar 26. Review.

PMID:
17386038
10.

Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers.

Rebbeck TR.

J Clin Oncol. 2000 Nov 1;18(21 Suppl):100S-3S. Review.

PMID:
11060335
11.

Molecular pathology of ovarian carcinomas.

Matias-Guiu X, Prat J.

Virchows Arch. 1998 Aug;433(2):103-11. Review.

PMID:
9737787
12.

[BRCA genes and ovarian neoplasms].

D'Andrea E, Montagna M, Menin C, Santacatterina M, Chieco-Bianchi L.

Tumori. 1999 May-Jun;85(3 Suppl 1):S35-7. Review. Italian. No abstract available.

PMID:
10542885
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk